RBC maintains Gilead Sciences at Sector Perform
RBC Capital maintained its Sector Perform rating on Gilead Sciences and raised its price target to $126.00 from $123.00.
Story updates
02:20:06 PM UTC
SquawkNews
Gilead Sciences Price Target Raised to $126.00/Share From $123.00 by RBC Capital